Celcuity Inc.

CELC

$63.88

Name : Celcuity Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $3,125,770,240.00

EPSttm : -4.72

Celcuity Inc.

$63.88

0.68%

$0.44

CELC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

25.47

Margin Of Safety %

Put/Call OI Ratio

0.59

EPS Next Q Diff

0.25

EPS Last/This Y

-1.1

EPS This/Next Y

4.89

Price

64.31

Target Price

150.85

Analyst Recom

Performance Q

-25.73

Upside

-356.3%

Beta

0.14

Ticker: CELC

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	CELC	63.2	0.45	1.57	18027
2026-10-14	CELC	59.9	0.43	0.13	17925
2026-10-15	CELC	60.82	0.36	0.02	20175
2026-10-16	CELC	56.6	0.36	0.53	20369
2026-10-19	CELC	57.09	0.39	0.09	19222
2026-10-20	CELC	60.36	0.38	2.62	19659
2026-10-21	CELC	61.62	0.38	0.04	19893
2026-10-22	CELC	65.61	0.38	0.06	19973
2026-10-23	CELC	65.3	0.39	0.82	20177
2026-10-26	CELC	65.85	0.39	0.56	20259
2026-10-27	CELC	68.13	0.39	0.00	20410
2026-10-28	CELC	69.46	0.39	0.18	20488
2026-10-29	CELC	69.32	0.39	0.52	20650
2026-10-30	CELC	69.17	0.39	0.11	20642
2026-11-02	CELC	67.09	0.38	0.15	20974
2026-11-03	CELC	69.74	0.39	0.10	20903
2026-11-04	CELC	69.28	0.39	0.86	21047
2026-11-05	CELC	63.95	0.39	0.36	21095
2026-11-06	CELC	66.76	0.39	30.01	21148
2026-11-09	CELC	70.12	0.59	1.04	24084
2026-11-10	CELC	67.01	0.59	0.02	24243
2026-11-11	CELC	64.33	0.59	0.02	24189
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	CELC	63.23	-93.6	-	-4.39
2026-10-14	CELC	59.92	-93.6	-	-4.39
2026-10-15	CELC	60.38	-93.6	-	-4.39
2026-10-16	CELC	56.58	-93.6	-	-4.39
2026-10-19	CELC	57.08	-93.6	-	-4.39
2026-10-20	CELC	57.08	-93.6	-	-4.39
2026-10-21	CELC	60.06	-93.6	-	-4.39
2026-10-22	CELC	65.65	-93.6	-	-4.39
2026-10-23	CELC	65.29	-93.6	-	-4.39
2026-10-26	CELC	65.82	-93.6	-	-4.39
2026-10-27	CELC	68.11	-93.6	-	-4.39
2026-10-28	CELC	69.44	-93.6	-	-4.39
2026-10-29	CELC	69.33	-93.6	-	-4.39
2026-10-30	CELC	69.12	-93.6	-	-4.39
2026-11-02	CELC	67.11	-93.6	-	-4.39
2026-11-03	CELC	69.72	-93.6	-	-4.39
2026-11-04	CELC	69.33	-93.6	-	-4.39
2026-11-05	CELC	63.90	-93.6	-	-4.52
2026-11-06	CELC	66.77	-96.8	-	-4.52
2026-11-09	CELC	70.35	-26.7	-	-4.52
2026-11-10	CELC	67.06	-61.6	-	-4.32
2026-11-11	CELC	64.31	-61.6	-	-4.32
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	CELC	-26.61	22.63	27.25
2026-10-14	CELC	-26.61	22.63	27.25
2026-10-15	CELC	-26.61	22.63	27.25
2026-10-16	CELC	-26.61	22.63	27.25
2026-10-19	CELC	-26.62	22.78	27.25
2026-10-20	CELC	-26.62	22.78	27.25
2026-10-21	CELC	-26.61	22.78	27.25
2026-10-22	CELC	-26.61	22.78	27.25
2026-10-23	CELC	-26.61	22.78	27.25
2026-10-26	CELC	-26.62	25.24	27.25
2026-10-27	CELC	-26.61	25.24	25.45
2026-10-28	CELC	-26.61	25.24	25.45
2026-10-29	CELC	-26.61	25.24	25.45
2026-10-30	CELC	-26.61	25.24	25.45
2026-11-02	CELC	-26.61	25.17	25.45
2026-11-03	CELC	-26.61	25.17	25.45
2026-11-05	CELC	-26.61	25.17	25.45
2026-11-06	CELC	-26.61	25.17	25.45
2026-11-09	CELC	-26.33	25.02	25.35
2026-11-10	CELC	-26.33	25.02	25.35
2026-11-11	CELC	-26.33	25.02	25.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.33

Avg. EPS Est. Current Quarter

-1.18

Avg. EPS Est. Next Quarter

-1.08

Insider Transactions

-26.33

Institutional Transactions

25.02

Beta

0.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

57.4

Max Drawdown 5-Year %

-70.8

Target Price

150.85

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-4.71

Average EPS Est. Cur. Y

-4.32

EPS Next Y. (Est.)

0.57

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.57

Return on Equity vs Sector %

319.4

Return on Equity vs Industry %

339

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

◆ CELC Healthcare

$64.32

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

9/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

4/10

RSI

Range 1M

57.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

12/30

Estimates

0/20

Inst/Vol

5/15

Options

6/10

EPS Yr

-36.4%

EPS NY

46.6%

52W%

11.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -10.9% upside

Quality

3/30

Valuation

0/30

Growth

9/25

Stability

9/10

LT Trend

4/5

Upside

-10.9%

Quality

CELC — P/E HistoricalDiagnostics & Research

Celcuity Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 155

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.

CELC

Latest News

—

Caricamento notizie per CELC…

stock quote shares CELC – Celcuity Inc. Stock Price stock today

news today CELC – Celcuity Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CELC – Celcuity Inc. yahoo finance google finance

stock history CELC – Celcuity Inc. invest stock market

stock prices CELC premarket after hours

ticker CELC fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CELC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y